Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference30 articles.
1. Deconstructing the molecular portraits of breast cancer;Prat;Mol Oncol,2011
2. Adjuvant therapy of triple negative breast cancer;Perez;Breast Cancer Res Treat,2010
3. Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research;Bosch;Cancer Treat Rev,2010
4. Triple-negative breast cancer: therapeutic options;Cleator;Lancet Oncol,2007
5. Triple-negative breast cancer: novel therapies and new directions;Pal;Maturitas,2009
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adjuvant chemotherapy for pT1abN0M0 triple-negative breast cancer: a systematic review and meta-analysis of published studies;European Journal of Cancer;2021-04
2. The hispanic landscape of triple negative breast cancer;Critical Reviews in Oncology/Hematology;2020-11
3. Triple negative breast cancer: Early stages management and evolution, a two years experience at the department of breast cancer of CHSF;Clinical Journal of Obstetrics and Gynecology;2020-06-30
4. Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis;PLOS ONE;2019-06-20
5. Ecotropic virus integration‑1 and calreticulin as novel prognostic markers in triple‑negative breast cancer: A retrospective cohort study;Oncology Letters;2019-06-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3